Acute kidney injury in hematological patients treated with CAR-T cells: risk factors, clinical presentation and impact on outcomes
Abstract Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematologic malignancies, yet it carries significant risks, including acute kidney injury (AKI). In this study, we investigated the risk factors and clinical impact of AKI in patients undergoing CAR-T cell...
Saved in:
| Main Authors: | Elisa Russo, Massimiliano Gambella, Anna Maria Raiola, Elena Beltrametti, Valentina Zanetti, Giuseppe Chirco, Francesca Viazzi, Emanuele Angelucci, Pasquale Esposito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-77720-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of CAR transgene expression to design semiautonomous CAR-T
by: Paweł Głowacki, et al.
Published: (2024-09-01) -
Hospital pharmacist’s roles and responsibilities with CAR-T medicines
by: María Estela Moreno-Martínez, et al.
Published: (2020-01-01) -
CAR-T Therapy Beyond B-Cell Hematological Malignancies
by: Martina Canichella, et al.
Published: (2025-01-01) -
Multicellular Cancer-Stroma Spheres (CSS) for In Vitro Assessment of CAR-T Cell-Associated Toxicity
by: Aigul R. Rakhmatullina, et al.
Published: (2024-11-01) -
New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies
by: Yuanyuan Yang, et al.
Published: (2024-11-01)